Study Design and Population: The Bisoprolol in COPD Study (BICS) was a double-blind, placebo-controlled randomized clinical trial conducted across 76 sites in the UK, including both primary and secondary care clinics. The study enrolled 515 patients with chronic obstructive pulmonary disease (COPD) who had moderate to severe airflow obstruction and a history of at least […]

The post RCT: Bisoprolol Does Not Reduce COPD Exacerbations in High-Risk Patients – JAMA appeared first on Links Medicus.